PAR-5359

N/A

Report date: 2021/12/27 13:50:55
NME

Base Information

Drug NamePAR-5359
Drug Alias NamePAR-5359
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong-A Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A